| Sources | Names Used |
|---|---|
| CTRPv2 | 1S,3R-RSL-3 |
| PharmacoGx | 1S,3R-RSL-3 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSCAN30 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | SLC45A2 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | FRMD6 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | SPATS1 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | CES1 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | PMEL | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | VPS18 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | TMEM144 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | FAM171A2 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | TSPAN10 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
